Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Distinct Hepatic Macrophage Populations in Lean and Obese Mice.

Mayoral Monibas R, Johnson AM, Osborn O, Traves PG, Mahata SK.

Front Endocrinol (Lausanne). 2016 Dec 6;7:152. doi: 10.3389/fendo.2016.00152. eCollection 2016. Review.

2.

8,9-Dehydrohispanolone-15,16-lactol diterpene prevents LPS-triggered inflammatory responses by inhibiting endothelial activation.

Jiménez-García L, Través PG, López-Fontal R, Herranz S, Higueras MA, de Las Heras B, Hortelano S, Luque A.

Biochem J. 2016 Jul 15;473(14):2061-71. doi: 10.1042/BCJ20160343. Epub 2016 May 6.

PMID:
27154204
3.

TAM receptors regulate multiple features of microglial physiology.

Fourgeaud L, Través PG, Tufail Y, Leal-Bailey H, Lew ED, Burrola PG, Callaway P, Zagórska A, Rothlin CV, Nimmerjahn A, Lemke G.

Nature. 2016 Apr 14;532(7598):240-244. doi: 10.1038/nature17630. Epub 2016 Apr 6.

4.

Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity.

Mayoral R, Osborn O, McNelis J, Johnson AM, Oh DY, Izquierdo CL, Chung H, Li P, Traves PG, Bandyopadhyay G, Pessentheiner AR, Ofrecio JM, Cook JR, Qiang L, Accili D, Olefsky JM.

Mol Metab. 2015 Mar 5;4(5):378-91. doi: 10.1016/j.molmet.2015.02.007. eCollection 2015 May.

5.

HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages.

Tawakol A, Singh P, Mojena M, Pimentel-Santillana M, Emami H, MacNabb M, Rudd JH, Narula J, Enriquez JA, Través PG, Fernández-Velasco M, Bartrons R, Martín-Sanz P, Fayad ZA, Tejedor A, Boscá L.

Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1463-71. doi: 10.1161/ATVBAHA.115.305551. Epub 2015 Apr 16.

6.

Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.

Lew ED, Oh J, Burrola PG, Lax I, Zagórska A, Través PG, Schlessinger J, Lemke G.

Elife. 2014 Sep 29;3. doi: 10.7554/eLife.03385.

7.

Sustained release of prostaglandin E₂ in fibroblasts expressing ectopically cyclooxygenase 2 impairs P2Y-dependent Ca²⁺-mobilization.

Pimentel-Santillana M, Través PG, Pérez-Sen R, Delicado EG, Martín-Sanz P, Miras-Portugal MT, Boscá L.

Mediators Inflamm. 2014;2014:832103. doi: 10.1155/2014/832103. Epub 2014 Aug 18.

8.

Diversification of TAM receptor tyrosine kinase function.

Zagórska A, Través PG, Lew ED, Dransfield I, Lemke G.

Nat Immunol. 2014 Oct;15(10):920-8. doi: 10.1038/ni.2986. Epub 2014 Sep 7.

9.

Anti-inflammatory actions of acanthoic acid-related diterpenes involve activation of the PI3K p110γ/δ subunits and inhibition of NF-κB.

Través PG, Pimentel-Santillana M, Rico D, Rodriguez N, Miethke T, Castrillo A, Theodorakis EA, Martín-Sanz P, Palladino MA, Boscá L.

Chem Biol. 2014 Aug 14;21(8):955-66. doi: 10.1016/j.chembiol.2014.06.005. Epub 2014 Jul 24.

10.

Pivotal role of protein tyrosine phosphatase 1B (PTP1B) in the macrophage response to pro-inflammatory and anti-inflammatory challenge.

Través PG, Pardo V, Pimentel-Santillana M, González-Rodríguez Á, Mojena M, Rico D, Montenegro Y, Calés C, Martín-Sanz P, Valverde AM, Boscá L.

Cell Death Dis. 2014 Mar 13;5:e1125. doi: 10.1038/cddis.2014.90.

11.

Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.

Moreno C, Prieto P, Macías Á, Pimentel-Santillana M, de la Cruz A, Través PG, Boscá L, Valenzuela C.

J Immunol. 2013 Dec 15;191(12):6136-46. doi: 10.4049/jimmunol.1300235. Epub 2013 Nov 18.

12.

Selective impairment of P2Y signaling by prostaglandin E2 in macrophages: implications for Ca2+-dependent responses.

Través PG, Pimentel-Santillana M, Carrasquero LM, Pérez-Sen R, Delicado EG, Luque A, Izquierdo M, Martín-Sanz P, Miras-Portugal MT, Boscá L.

J Immunol. 2013 Apr 15;190(8):4226-35. doi: 10.4049/jimmunol.1203029. Epub 2013 Mar 11.

13.

Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.

Través PG, Luque A, Hortelano S.

Mediators Inflamm. 2012;2012:568783. doi: 10.1155/2012/568783. Epub 2012 Dec 18. Review.

14.

Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis.

Burstyn-Cohen T, Lew ED, Través PG, Burrola PG, Hash JC, Lemke G.

Neuron. 2012 Dec 20;76(6):1123-32. doi: 10.1016/j.neuron.2012.10.015.

15.

Role of the tumor suppressor ARF in macrophage polarization: Enhancement of the M2 phenotype in ARF-deficient mice.

Herranz S, Través PG, Luque A, Hortelano S.

Oncoimmunology. 2012 Nov 1;1(8):1227-1238.

16.

Tumor suppressor ARF: The new player of innate immunity.

Través PG, Luque A, Hortelano S.

Oncoimmunology. 2012 Sep 1;1(6):946-947.

17.

Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives.

Través PG, López-Fontal R, Cuadrado I, Luque A, Boscá L, de las Heras B, Hortelano S.

Oncogene. 2013 Jan 10;32(2):259-68. doi: 10.1038/onc.2012.23. Epub 2012 Feb 6.

PMID:
22310289
18.

Relevance of the MEK/ERK signaling pathway in the metabolism of activated macrophages: a metabolomic approach.

Través PG, de Atauri P, Marín S, Pimentel-Santillana M, Rodríguez-Prados JC, Marín de Mas I, Selivanov VA, Martín-Sanz P, Boscá L, Cascante M.

J Immunol. 2012 Feb 1;188(3):1402-10. doi: 10.4049/jimmunol.1101781. Epub 2011 Dec 21.

19.

The tumor suppressor ARF regulates innate immune responses in mice.

Través PG, López-Fontal R, Luque A, Hortelano S.

J Immunol. 2011 Dec 15;187(12):6527-38. doi: 10.4049/jimmunol.1004070. Epub 2011 Nov 16.

20.

Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation.

Rodríguez-Prados JC, Través PG, Cuenca J, Rico D, Aragonés J, Martín-Sanz P, Cascante M, Boscá L.

J Immunol. 2010 Jul 1;185(1):605-14. doi: 10.4049/jimmunol.0901698. Epub 2010 May 24.

Supplemental Content

Loading ...
Support Center